These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies. Chakrabarti BK; Pancera M; Phogat S; O'Dell S; McKee K; Guenaga J; Robinson J; Mascola J; Wyatt RT AIDS Res Hum Retroviruses; 2011 Aug; 27(8):877-87. PubMed ID: 21158699 [TBL] [Abstract][Full Text] [Related]
7. Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41. Gorny MK; Zolla-Pazner S J Virol; 2000 Jul; 74(13):6186-92. PubMed ID: 10846104 [TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a broadly cross-reactive HIV-1 human monoclonal antibody that binds to both gp120 and gp41. Zhang MY; Yuan T; Li J; Rosa Borges A; Watkins JD; Guenaga J; Yang Z; Wang Y; Wilson R; Li Y; Polonis VR; Pincus SH; Ruprecht RM; Dimitrov DS PLoS One; 2012; 7(9):e44241. PubMed ID: 22970187 [TBL] [Abstract][Full Text] [Related]
9. Binding of the 2F5 monoclonal antibody to native and fusion-intermediate forms of human immunodeficiency virus type 1 gp41: implications for fusion-inducing conformational changes. de Rosny E; Vassell R; Jiang S; Kunert R; Weiss CD J Virol; 2004 Mar; 78(5):2627-31. PubMed ID: 14963170 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Denizot M; Varbanov M; Espert L; Robert-Hebmann V; Sagnier S; Garcia E; Curriu M; Mamoun R; Blanco J; Biard-Piechaczyk M Autophagy; 2008 Nov; 4(8):998-1008. PubMed ID: 18818518 [TBL] [Abstract][Full Text] [Related]
11. Antigenic implications of human immunodeficiency virus type 1 envelope quaternary structure: oligomer-specific and -sensitive monoclonal antibodies. Broder CC; Earl PL; Long D; Abedon ST; Moss B; Doms RW Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11699-703. PubMed ID: 7972127 [TBL] [Abstract][Full Text] [Related]
12. Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein. Edwards TG; Wyss S; Reeves JD; Zolla-Pazner S; Hoxie JA; Doms RW; Baribaud F J Virol; 2002 Mar; 76(6):2683-91. PubMed ID: 11861835 [TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer. Litwin V; Nagashima KA; Ryder AM; Chang CH; Carver JM; Olson WC; Alizon M; Hasel KW; Maddon PJ; Allaway GP J Virol; 1996 Sep; 70(9):6437-41. PubMed ID: 8709277 [TBL] [Abstract][Full Text] [Related]
14. Effects of the I559P gp41 change on the conformation and function of the human immunodeficiency virus (HIV-1) membrane envelope glycoprotein trimer. Alsahafi N; Debbeche O; Sodroski J; Finzi A PLoS One; 2015; 10(4):e0122111. PubMed ID: 25849367 [TBL] [Abstract][Full Text] [Related]
15. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120. Salzwedel K; Smith ED; Dey B; Berger EA J Virol; 2000 Jan; 74(1):326-33. PubMed ID: 10590121 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the interaction of the human immunodeficiency virus type 1 gp120 envelope glycoprotein with the gp41 transmembrane glycoprotein. Wyatt R; Desjardin E; Olshevsky U; Nixon C; Binley J; Olshevsky V; Sodroski J J Virol; 1997 Dec; 71(12):9722-31. PubMed ID: 9371638 [TBL] [Abstract][Full Text] [Related]
17. Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein. Hoffman TL; LaBranche CC; Zhang W; Canziani G; Robinson J; Chaiken I; Hoxie JA; Doms RW Proc Natl Acad Sci U S A; 1999 May; 96(11):6359-64. PubMed ID: 10339592 [TBL] [Abstract][Full Text] [Related]
18. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains. Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935 [TBL] [Abstract][Full Text] [Related]
19. Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. Golding H; Zaitseva M; de Rosny E; King LR; Manischewitz J; Sidorov I; Gorny MK; Zolla-Pazner S; Dimitrov DS; Weiss CD J Virol; 2002 Jul; 76(13):6780-90. PubMed ID: 12050391 [TBL] [Abstract][Full Text] [Related]